Literature DB >> 27043203

A Comparison of SHILLA GROWTH GUIDANCE SYSTEM and Growing Rods in the Treatment of Spinal Deformity in Children Less Than 10 Years of Age.

Scott J Luhmann1, Richard E McCarthy.   

Abstract

BACKGROUND: The purpose of this study was to compare the outcomes of the SHILLA GROWTH GUIDANCE SYSTEM and "intermittent distraction growing rod" (IDGR) in the treatment of children (less than 10 y of age) with progressive spinal deformity. This was a multicenter retrospective study of the SHILLA used as an alternative treatment to IDGR to support an HDE submission for Food and Drug Administration approval.
METHODS: Inclusion criteria were progressive scoliosis in a patient less than 10 years of age at index procedure. The study population consisted of 19 SHILLA and 6 IDGR patients whose mean age was 6.1 and 5.8 years, respectively. Group demographics were similar between the 2 groups.
RESULTS: The initial major curve magnitude was 70.3 degrees for SHILLA and 68.3 degrees for IDGR, which decreased postoperatively to 22.4 degrees (68.1% improvement) and 32.2 degrees (52.9% improvement). During the first 4 years the correction for SHILLA varied from 40.5% to 53.4% and for IDGR from 40.9% to 56.9%. At last follow-up, T1-S1 length was 32.9 cm for SHILLA (4.2 increase from preoperation) and 34.0 cm (5.0 cm increase from preoperation) for IDGR. Average growth per month from T1-S1: SHILLA 0.14 cm, IDGR 0.11 cm. Sagittal T2-T12 preoperatively was 36.3 degrees for SHILLA and 30.0 degrees for IDGR. There were 29 reoperations in 12 of the 19 SHILLA patients (63.2%) and 40 reoperations in all 6 of the IDGR patients (100%) related to the index procedure.
CONCLUSIONS: The SHILLA GROWTH GUIDANCE SYSTEM compares favorably with traditional IDGR constructs in terms of correction of the major curve, spinal length and growth, and maintenance of sagittal alignment. The >4-fold decrease in additional surgeries makes the SHILLA an attractive alternative to minimize comorbidities associated with additional surgeries. LEVELS OF EVIDENCE: Level III.

Entities:  

Mesh:

Year:  2017        PMID: 27043203     DOI: 10.1097/BPO.0000000000000751

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

1.  A comparison of the inflammatory host response to particulate debris adjacent to unlocked and locked screws of a growth guidance system for early onset scoliosis.

Authors:  Jeffrey M Toth; Felix Ankomah; Noriaki Kawakami; Koki Uno
Journal:  Eur Spine J       Date:  2022-06-13       Impact factor: 2.721

2.  Active Apex Correction (Modified SHILLA Technique) Versus Distraction-Based Growth Rod Fixation: What Do the Correction Parameters Say?

Authors:  Aakash Agarwal; Loai Aker; Alaaeldin Azmi Ahmad
Journal:  Spine Surg Relat Res       Date:  2019-08-16

3.  Cost-Utility Analysis of Anterior Vertebral Body Tethering versus Spinal Fusion in Idiopathic Scoliosis from a US Integrated Healthcare Delivery System Perspective.

Authors:  David W Polly; A Noelle Larson; Amer F Samdani; William Rawlinson; Hannah Brechka; Alex Porteous; William Marsh; Richard Ditto
Journal:  Clinicoecon Outcomes Res       Date:  2021-03-15

4.  3-Year follow-up of a single magnetically controlled growing rod with contralateral gliding system and apical control for early onset scoliosis.

Authors:  Sebastiaan P J Wijdicks; Simon Toftgaard Skov; Haisheng Li; René M Castelein; Moyo C Kruyt; Cody Bünger
Journal:  Spine Deform       Date:  2020-03-30

Review 5.  Treatment of early-onset scoliosis: techniques, indications, and complications.

Authors:  Yan-Bin Zhang; Jian-Guo Zhang
Journal:  Chin Med J (Engl)       Date:  2020-02-05       Impact factor: 2.628

6.  Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective.

Authors:  Scott J Luhmann; Eoin M McAughey; Stacey J Ackerman; David B Bumpass; Richard E McCarthy
Journal:  Clinicoecon Outcomes Res       Date:  2018-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.